Gareth Morgan, MD

Gareth Morgan, MD, director of Myeloma Research at NYU Langone's Perlmutter Cancer Center, discusses where he sees the field of CAR T cells headed for the treatment of patients with multiple myeloma.

While there are many treatment options available, these patients are still relapsing, Morgan says. The treatments also have many side effects, so cellular therapy could replace many of the current therapies that are available.

Videos

Gareth Morgan, MD, discusses where he sees the field headed for the treatment of patients with multiple myeloma.

Gareth Morgan, MD | Authors

Articles

Evaluating the Role of CAR T Cells in Multiple Myeloma